At Micronoma we are putting everything we have into ensuring that development of diagnostics like our Oncobiota™ platform will be a key propellent for creating new opportunities in precision medicine by identifying cancer at its earliest stages. But first, a quick...
Mauka Manuwai joined the Micronoma team in July 2022 as a Research Associate II. Originally from Medford, Oregon, he decided to trade the evergreen trees for the salty waves and sandy beaches of San Diego in 2021. In Hawaiian, his name Mauka means: Towards the...
Our recent collaboration with the Weizmann Institute of Science and the University of California San Diego found that fungi are ubiquitous in human cancer types and often interact with bacteria in synergistic, rather than competitive ways. This is the latest chapter...
Todd Czerwinski joined the Micronoma team formally in May of 2022 as the Vice President of Business Development. Originally from the suburbs of Detroit, he has been in San Diego since the summer of 1995 (he wants us to know it was early September ’95 –...
At Micronoma, we turn to science first to guide us down the road to delivering the first diagnostic platform technology using the microbiome to detect early-stage cancer. At the same time, we keep a watchful eye on our resources so we can steer clear of the...
Celia Sepulveda joined Micronoma formally in April of 2022 as the Corporate Communications Director, though she has been working with Micronoma as a consultant from the announced launch in fall of 2020. Born in Santa Rosa, California and raised in New Jersey, she has...
